For release: 07.00,
(the "Company" or "Good Life Plus")
SUBSCRIPTION OF
Convertible Loan Note Instrument (CLN)
The CLN has the following key terms:
· The CLN will automatically convert into ordinary shares on
o 2.2p per share; or
o The price of any subsequent equity fundraise that occurs before
· The CLN is open for subscription until
· The instrument allows for the issuance of up to
Boatside Investments has agreed to subscribe for
Intended Use of Proceeds
The subscription by Boatside Investments further demonstrates ongoing confidence in the Company's growth strategy and long-term value creation and the proceeds will be deployed to support the Company's growth initiatives, including:
· expanding customer acquisition channels;
· enhancing its premium subscription offering;
· strengthening operational capabilities; and
· further exploring strategic partnerships and above-the-line advertising opportunities.
· international expansion
Update on Operations
Since the Company announced the partnership with a leading
"The continued support from our largest external shareholder represents a strong endorsement of both our progress to date and the scale of the opportunity ahead. The investment strengthens our ability to accelerate growth across key areas and seize new market opportunities. We are excited to build on this momentum, deepen our partnerships, and continue delivering exceptional value for our customers while driving long-term shareholder returns."
Related Party Transaction
As the ultimate beneficial owners of Boatside Investments currently hold more than 10% of the Company's issued share capital, the Subscription constitutes a related party transaction under Rule 4.6 of the AQSE Growth Market Access Rulebook. The Directors of the Company, having exercised reasonable care, skill, and diligence, consider that the terms of the Subscription are fair and reasonable as far as shareholders are concerned.
Admission and Total Voting Rights
No immediate changes to the Company's issued share capital or total voting rights arise as a result of the creation of the CLN instrument. The details of any share issuance, including total voting rights, will be announced upon conversion of the CLN.
This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended).
The Directors of the Company take responsibility for this announcement.
- Ends -
For further information, please contact:
AQSE Corporate Advisor
Rosewood
goodlifeplus@rosewoodpr.co.uk
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the